Triazavirin: Perbedaan antara revisi

Konten dihapus Konten ditambahkan
Ariyanto (bicara | kontrib)
HsfBot (bicara | kontrib)
k replaced: nampaknya → tampaknya
 
(7 revisi perantara oleh 2 pengguna tidak ditampilkan)
Baris 1:
{{Drugbox
| IUPAC_name = 2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4]triazin-7(4''H'')-one
Baris 30 ⟶ 29:
}}
 
'''Triazavirin''' ('''TZV''', '''Riamilovir''') adalah antivirus analog [[nukleotida]] yang awalnya dikembangkan di Rusia yang telah menunjukkan kemanjuran terhadap [[influenza]] A dan B, termasuk strain [[H5n1|H5N1]].<ref>{{Cite journal|last=Kiselev|first=O. I.|last2=Deeva|first2=E. G.|last3=Mel'nikova|first3=T. I.|last4=Kozeletskaia|first4=K. N.|last5=Kiselev|first5=A. S.|last6=Rusinov|first6=V. L.|last7=Charushin|first7=V. N.|last8=Chupakhin|first8=O. N.|date=2012-11|title=[A new antiviral drug Triazavirin: results of phase II clinical trial]|url=https://www.ncbi.nlm.nih.gov/pubmed/23477247|journal=Voprosy Virusologii|volume=57|issue=6|pages=9–12|issn=0507-4088|pmid=23477247}}</ref><ref>{{Cite journal|last=Vincent|first=Martin J.|last2=Bergeron|first2=Eric|last3=Benjannet|first3=Suzanne|last4=Erickson|first4=Bobbie R.|last5=Rollin|first5=Pierre E.|last6=Ksiazek|first6=Thomas G.|last7=Seidah|first7=Nabil G.|last8=Nichol|first8=Stuart T.|date=2005-08-22|title=Chloroquine is a potent inhibitor of SARS coronavirus infection and spread|url=https://www.ncbi.nlm.nih.gov/pubmed/16115318|journal=Virology Journal|volume=2|pages=69|doi=10.1186/1743-422X-2-69|issn=1743-422X|pmc=1232869|pmid=16115318}}</ref><ref>{{Cite journal|last=Karpenko|first=Inna|last2=Deev|first2=Sergey|last3=Kiselev|first3=Oleg|last4=Charushin|first4=Valerey|last5=Rusinov|first5=Vladimir|last6=Ulomsky|first6=Eugeney|last7=Deeva|first7=Ella|last8=Yanvarev|first8=Dmitry|last9=Ivanov|first9=Alexander|date=2010-05|title=Antiviral properties, metabolism, and pharmacokinetics of a novel azolo-1,2,4-triazine-derived inhibitor of influenza A and B virus replication|url=https://www.ncbi.nlm.nih.gov/pubmed/20194696|journal=Antimicrobial Agents and Chemotherapy|volume=54|issue=5|pages=2017–2022|doi=10.1128/AAC.01186-09|issn=1098-6596|pmc=2863629|pmid=20194696}}</ref><ref>{{Cite journal|last=Shvetsov|first=Alexey V.|last2=Zabrodskaya|first2=Yana A.|last3=Nekrasov|first3=Peter A.|last4=Egorov|first4=Vladimir V.|date=2018-07-27|title=Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure|url=https://doi.org/10.1080/07391102.2017.1367329|journal=Journal of Biomolecular Structure and Dynamics|volume=36|issue=10|pages=2694–2698|doi=10.1080/07391102.2017.1367329|issn=0739-1102|pmid=28828928}}</ref>
Menurut riset, {{PAGENAMEPURE}} nampaknyatampaknya mampu mengurangi dampak dari penyakit flu dan juga komplikasi penyakit terkait.<ref>{{Cite web|url=https://www.rt.com/russia/480037-china-tests-russian-drug-coronavirus/|title=China tests Russian anti-viral drug which might treat coronavirus as Moscow warns of possible 'mass outbreak'|website=RT International|language=en|access-date=2020-04-20}}</ref>
Antivirus ini memiliki inti dari ''novel triazolotriazine,'' yang mewakili kelas struktural baru dari obat-obatan antivirus non-nukleosida.<ref name=":0">{{Cite journal|last=Rusinov|first=Vladimir L.|last2=Sapozhnikova|first2=Irina M.|last3=Ulomskii|first3=Evgeny N.|last4=Medvedeva|first4=Natalia R.|last5=Egorov|first5=Vladimir V.|last6=Kiselev|first6=Oleg I.|last7=Deeva|first7=Ella G.|last8=Vasin|first8=Andrey V.|last9=Chupakhin|first9=Oleg N.|date=2015-03-01|title=Nucleophilic substitution of nitro group in nitrotriazolotriazines as a model of potential interaction with cysteine-containing proteins|url=https://doi.org/10.1007/s10593-015-1695-4|journal=Chemistry of Heterocyclic Compounds|language=en |volume=51|issue=3|pages=275–280|doi=10.1007/s10593-015-1695-4|issn=1573-8353}}</ref>
 
==Manfaat==
 
Triazavirin, yang dikembangkan di Yekaterinburg’s Ural Federal University, awalnya dikembangkan untuk menangani virus ‘Flu Burung’ (H5N1), dank arena adanya persamaan antar kedua virus, para peneliti merasa perlu untuk mencoba khasiat obatnya pada pasien corona.<ref name=loginova>Loginova SIa, Borisevich SV, Maksimov VA, et al. Antibiot Khimioter. 2007;52(11-12):18‐20.</ref>
Triazavirin pada mulanya dikembangkan di [[Akademi Ilmu Pengetahuan Rusia]], Universitas Federal Ural di [[Ekaterinburg]], [[Rusia]] yang dikembangkan untuk mengatasi wabah dari virus [[Flu burung|Flu Burung]] ([[H5N1]]), kemudian dikarenakan terdapat beberapa persamaan dengan [[koronavirus]], maka para peneliti merasa perlu untuk mencoba meneliti khasiat obatnya pada pasien korona.<ref name=":0" /><ref name=loginova>Loginova SIa, Borisevich SV, Maksimov VA, et al. Antibiot Khimioter. 2007;52(11-12):18‐20.</ref><ref name=":1">{{Cite web|url=https://pubmed.ncbi.nlm.nih.gov/19275052/|title=[Investigation of Triazavirin Antiviral Activity Against Influenza A Virus (H5N1) in Cell Culture]|last=SIa|first=Loginova|last2=Sv|first2=Borisevich|date=2007|website=Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic]|language=en|pmid=19275052|access-date=2020-05-03|last3=Va|first3=Maksimov|last4=Vp|first4=Bondarev|last5=Sk|first5=Kotovskaia|last6=Vl|first6=Rusinov|last7=Vn|first7=Charushin}}</ref>
Sebagian besar penelitian dilakukan dalam rangka menguji aktivitas anti-infuenza.<ref name="loginova" /><ref name=":1" />
 
== Referensi ==